Exploring the Effect of an Intervention on Women's Physical Activity Behaviour
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03601663 |
|
Recruitment Status :
Completed
First Posted : July 26, 2018
Last Update Posted : March 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Physical Activity | Behavioral: Physical Activity Information Behavioral: Physical Activity Monitoring Behavioral: Autonomy-support | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 49 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Exploring the Effect of an eHealth Intervention on Women's Physical Activity Behaviour |
| Actual Study Start Date : | September 1, 2018 |
| Actual Primary Completion Date : | April 22, 2019 |
| Actual Study Completion Date : | August 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Group 1
Participants in the main experimental group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, a wearable activity tracker to support self-monitoring, and autonomy-support delivered through weekly emails to help enhance motivation for physical activity.
|
Behavioral: Physical Activity Information
Participants will receive a copy of the Canadian Physical Activity Guidelines. Behavioral: Physical Activity Monitoring Participants will receive a wearable activity tracker (Polar A300). Behavioral: Autonomy-support Participants will receive eight autonomy-supportive weekly emails containing information and activities to help them set goals and make changes to become physically active. |
|
Active Comparator: Group 2
Participants in this comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity, and a wearable activity tracker to support self-monitoring. They will not receive any specific support to enhance motivation for physical activity.
|
Behavioral: Physical Activity Information
Participants will receive a copy of the Canadian Physical Activity Guidelines. Behavioral: Physical Activity Monitoring Participants will receive a wearable activity tracker (Polar A300). |
|
Active Comparator: Group 3
Participants in this information-only comparison group will receive a copy of the Canadian Physical Activity Guidelines that provide basic information about and recommendations for physical activity.
|
Behavioral: Physical Activity Information
Participants will receive a copy of the Canadian Physical Activity Guidelines. |
- Physical activity behaviour: International Physical Activity Questionnaire Short Form (IPAQ-S) [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in self-reported physical activity (over the past 7 days) from baseline to post-intervention, and from post-intervention to follow-up.
- Physical activity behaviour: Custom strength and resistance training questionnaire [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in strength and resistance training habits from baseline to post-intervention, and from post-intervention to follow-up.
- Physical activity behaviour: Direct measure [ Time Frame: Duration of intervention phase (8 weeks). ]Change in weekly directly measured levels of physical activity as measured by accelerometers (Polar A300), which will be worn by participants assigned to Group 1 and Group 2 during waking hours for the duration of the intervention.
- Perceived autonomy support: Perceived Autonomy Support Scale for Exercise Settings (PASSES; Hagger et al., 2007) [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in perceived autonomy support for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
- Basic psychological need satisfaction: Psychological Need Satisfaction in Exercise Scale (PNSE; Wilson, Rogers, Rodgers, & Wild, 2006) [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in basic psychological need satisfaction for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
- Motivational regulations: Behavioral Regulation in Exercise Questionnaire (BREQ-2R; Markland & Tobin, 2004; Wilson, Rodgers, Loitz, & Scime, 2006) [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in motivational regulations for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
- Basic psychological need thwarting: Psychological Need Thwarting Scale (PNTS; Bartholomew, Ntoumanis, Ryan, & Thøgersen-Ntoumani, 2011) [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in basic psychological need thwarting activity from baseline to post-intervention, and from post-intervention to follow-up.
- Positive and Negative Affect Schedule (I-PANAS-SF; Thompson, 2016; Watson, Clark, & Tellegen, 1988). [ Time Frame: : Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in affect from baseline to post-intervention, and from post-intervention to follow-up.
- Vitality: Subjective Vitality Scale (Ryan & Frederick, 1997). [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in vitality affect from baseline to post-intervention, and from post-intervention to follow-up.
- Depression: Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001). [ Time Frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21). ]Change in depressive symptoms from baseline to post-intervention, and from post-intervention to follow-up.
- Wearable activity tracker usage: Multiple choice questions [ Time Frame: Post-intervention (week 9). ]Frequency of wearable activity tracker usage in general during the intervention phase for participants randomized to Group 1 or Group 2.
- Recruitment rates [ Time Frame: Duration of recruitment and intervention phases (9 weeks). ]The number of eligible participants who enrol in the study out of the number assessed for eligibility.
- Retention rates [ Time Frame: Duration of recruitment and intervention phases (9 weeks). ]The number of participants completing all scheduled assessments.
- Acceptability: Open ended questions [ Time Frame: Duration of recruitment and intervention phases (9 weeks). ]For participants randomized to Group 1, what participants liked, disliked, and would change about the intervention.
- Body mass [ Time Frame: Baseline (week 0) and post-intervention (week 9). ]Change in body mass measured from baseline to post-intervention as determined using a scale (Tanita BWB 800S).
- Body composition [ Time Frame: Baseline (week 0) and post-intervention (week 9). ]Change in body composition from baseline to post-intervention as determined by a scale (Tanita BWB 800S) that uses bioelectrical impedance to assess body composition.
- Waist circumference [ Time Frame: Baseline (week 0) and post-intervention (week 9). ]Change in waist circumference from baseline to post-intervention as measured using a measuring tape.
- Sociodemographic questionnaire [ Time Frame: Baseline (week 0). ]Sociodemographic and health information will be collected at baseline to describe the sample. Measures include age, marital status, race, level of education, employment status, household income, number and age of children, self-rated health, medical conditions, menstrual status, smoking history, and weight-related goals.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
All participants will need to meet the following inclusion criteria to participate in the intervention:
- Are a woman between the ages of 18 and 65 years
- Can understand, read, and speak in English
- Are able to safely engage in physical activity
- Are not currently pregnant or lactating
- Currently participating in less than 150 minutes of moderate or vigorous intensity physical activity and less than two strength training sessions per week
- Are overweight or obese (i.e., have a body mass index greater than 25kg/m2)
- Have access to the Internet and an email account
- Have not used a wearable activity tracker within the past year (e.g., Fitbit, Apple Watch, Garmin, Polar)
- Live within 50km of the University of Ottawa
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03601663
| Canada, Ontario | |
| University of Ottawa | |
| Ottawa, Ontario, Canada, K1N6N5 | |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jennifer Brunet, Associate Professor, University of Ottawa |
| ClinicalTrials.gov Identifier: | NCT03601663 |
| Other Study ID Numbers: |
eHealth_Women_PA |
| First Posted: | July 26, 2018 Key Record Dates |
| Last Update Posted: | March 24, 2020 |
| Last Verified: | March 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
physical activity obesity pilot study |
randomized controlled trial women eHealth |

